174 related articles for article (PubMed ID: 11499841)
1. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases.
Fukushima N; Mukai K; Sakamoto M; Hasebe T; Shimada K; Kosuge T; Kinoshita T; Hirohashi S
Virchows Arch; 2001 Jul; 439(1):6-13. PubMed ID: 11499841
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
3. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
6. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.
Kim J; Jang KT; Mo Park S; Lim SW; Kim JH; Lee KH; Lee JK; Heo JS; Choi SH; Choi DW; Rhee JC; Lee KT
Tumour Biol; 2011 Jun; 32(3):535-42. PubMed ID: 21190101
[TBL] [Abstract][Full Text] [Related]
8. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
[TBL] [Abstract][Full Text] [Related]
9. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas.
Tajiri T; Tate G; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohosh T
Pancreas; 2004 Aug; 29(2):116-22. PubMed ID: 15257103
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
Yogi T; Hijioka S; Imaoka H; Mizuno N; Hara K; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Niwa Y; Yoshimura K; Bhatia V; Fujita J; Yamao K
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
[TBL] [Abstract][Full Text] [Related]
11. Significance of aggressive surgery for an invasive carcinoma derived from an intraductal papillary mucinous neoplasm diagnosed preoperatively as borderline resectable.
Aimoto T; Mizutani S; Kawano Y; Suzuki H; Uchida E
J Nippon Med Sch; 2013; 80(5):371-7. PubMed ID: 24189355
[TBL] [Abstract][Full Text] [Related]
12. Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Nov; 54(11):1412-1418. PubMed ID: 31680568
[No Abstract] [Full Text] [Related]
13. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.
Inagaki Y; Seyama Y; Hasegawa K; Tang W; Kokudo N
Drug Discov Ther; 2014 Aug; 8(4):173-7. PubMed ID: 25047009
[TBL] [Abstract][Full Text] [Related]
14. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
Partelli S; Fernandez-Del Castillo C; Bassi C; Mantovani W; Thayer SP; Crippa S; Ferrone CR; Falconi M; Pederzoli P; Warshaw AL; Salvia R
Ann Surg; 2010 Mar; 251(3):477-82. PubMed ID: 20142730
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
[TBL] [Abstract][Full Text] [Related]
16. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
18. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
19. Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas.
Okada K; Hirabayashi K; Imaizumi T; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Biomed Res; 2010 Feb; 31(1):13-9. PubMed ID: 20203415
[TBL] [Abstract][Full Text] [Related]
20. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
